James R. Murphy

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

Myron M. Levine, V. Nussenzweig, M. Levine, 1987, Nature.

Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

M. F. Edwards, M. Levine, J. Morris, 1987, The Journal of clinical investigation.

Immunogenicity of Salmonella typhi Ty21a vaccine for young children

M. Levine, G. Losonsky, J. Olson, 1991, Infection and immunity.

Plaque Assay for Rickettsia mooseri in Tissue Samples 1

C. Wisseman, James R. Murphy, Lillian B. Snyder, 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes.

J. Murphy, D. Watts, C. Hayes, 1993, The American journal of tropical medicine and hygiene.

Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection

D. Herrington, J. Murphy, James R. Murphy, 1989, Journal of clinical microbiology.

Host defenses in murine malaria: analysis of the mechanisms of immunity to Plasmodium berghei generated in response to immunization with formalin-killed blood-stage parasites

J. Murphy, James R. Murphy, 1979, Infection and immunity.